
March 3 (Reuters) - Teva Pharmaceutical Industries Ltd TEVA.TA:
TEVA AND BLACKSTONE LIFE SCIENCES ANNOUNCE $400 MILLION STRATEGIC GROWTH CAPITAL AGREEMENT TO ADVANCE DUVAKITUG
TEVA: AS PART OF FUNDING ARRANGEMENT, TEVA WILL PAY BXLS A MILESTONE PAYMENT FOR DUVAKITUG
TEVA: BXLS ALSO ELIGIBLE TO RECEIVE COMMERCIAL MILESTONES & LOW SINGLE-DIGIT ROYALTIES ON DUVAKITUG WORLDWIDE SALES